Personalized weight loss programs with compounded GLP-1 medications, guided by licensed providers and supported by cutting-edge telehealth.
Quick Weight Loss Shop has partnered with GrowRx, a U.S.-based leader in advanced peptide formulations, to bring members access to the latest research-backed wellness innovations.
Select the program and duration that best fits your goals.
Complete a quick eligibility form and submit payment to begin your program. Enrollment does not guarantee treatment or approval.
Answer a detailed medical questionnaire so a licensed provider can review your health history. Visit type (asynchronous or live video/call) is determined automatically based on state requirements.
If approved, eligible medications or products are shipped directly to you.
Manage your program, monitor progress, and access support through your secure patient portal.
Manage your program, monitor progress, and access support through your secure patient portal.
Images shown is for illustrative purposes only and does not represent actual medication packaging or labeling.
Learn the differences between our Semaglutide-based and Tirzepatide-based programs
and see which may align with your goals.
Foundational support • Single-pathway approach • Common starting option
Broader metabolic signaling • Dual-pathway support • Advanced option
| Category | BMI |
|---|---|
| Underweight | < 18.5 |
| Normal weight | 18.5 – 24.9 |
| Overweight | 25.0 – 29.9 |
| Obesity (Class I) | 30.0 – 34.9 |
| Obesity (Class II) | 35.0 – 39.9 |
| Extreme Obesity (Class III) | ≥ 40.0 |
BMI Disclosure: A current Body Mass Index (BMI) is required to proceed and assess program eligibility
Steady Weight Loss Support
Individuals new to GLP-1–based programs or those seeking a familiar, well-established option.
Enhanced Metabolic Support
Individuals interested in a dual-pathway option, subject to provide
review.
Medical decisions are made by licensed healthcare providers. Medications, if prescribed, are dispensed by licensed pharmacies. Program enrollment does not guarantee treatment or approval.
Many patients begin with a Semaglutide program, and their provider can help guide next steps after reviewing their medical intake.
Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Actual product packaging may appear differently than shown. Charts for illustrative purpose only.
Quick Weight Loss Shop is a telehealth platform that facilitates virtual care by connecting patients with independently licensed healthcare providers. These providers evaluate each patient’s medical history, current health status, and treatment goals to determine whether prescription therapy may be appropriate. All medical decisions, including prescribing, are made solely by the provider.
When clinically appropriate, a licensed healthcare provider may prescribe compounded Semaglutide or compounded Tirzepatide. These medications are prepared by licensed U.S. compounding pharmacies pursuant to a patient-specific prescription. Not all patients will qualify for medication therapy.
Licensed providers review each patient’s health history, current medications, laboratory data (when applicable), and treatment goals. Based on this clinical evaluation, the provider determines whether Semaglutide, Tirzepatide, or no medication at all is appropriate. Medication selection and dosing are individualized and may change over time.
No. Quick Weight Loss Shop does not provide brand-name medications. Compounded medications are custom-prepared formulations that may contain the same active ingredients as commercially available products but are not reviewed or approved by the U.S. Food and Drug Administration (FDA).
No. Services are offered on a self-pay basis. Insurance is not required, and Quick Weight Loss Shop does not submit insurance claims on behalf of patients.
Yes. Ongoing medical oversight is provided by licensed healthcare providers. Providers may adjust dosing, evaluate tolerance, and reassess treatment suitability based on patient-reported outcomes and clinical judgment.
All prescription medications carry potential risks and side effects. Commonly reported effects associated with medications such as Semaglutide or Tirzepatide may include gastrointestinal symptoms, appetite changes, or fatigue. Patients should discuss all risks and benefits with their provider prior to starting therapy.
Yes. Ongoing medical oversight is provided by licensed healthcare providers. Providers may adjust dosing, evaluate tolerance, and reassess treatment suitability based on patient-reported outcomes and clinical judgment.
Yes. Patients may discontinue treatment at any time. Providers may offer guidance on safe discontinuation when medically appropriate.
Yes. Quick Weight Loss Shop utilizes HIPAA-compliant systems to protect patient privacy and safeguard health information.
Prescription Process: Online evaluations with independent licensed medical professionals determine prescription appropriateness. Physicians may prescribe FDA-approved or compounded medications based on patient needs and clinical necessity. The FDA does not review compounded medications for safety or effectiveness. Medication Access: Product packaging may differ from images shown. Data Usage: You consent to our Privacy Policy. You consent to Quick Weight Loss Shop using your information for third-party advertising, including targeted ads on platforms like Facebook and Google. This includes using hashed and de-identified data for custom audiences.